NCT03469596View on ClinicalTrials.gov

Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

May 1, 2017

Study Completion Date

December 31, 2017

Conditions
Anal Carcinoma
Interventions
DIAGNOSTIC_TEST

MRI sequence

several MRI sequence before and after contrast product injection.

Trial Locations (1)

75014

Groupe Hospitalier Paris Saint Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT03469596 - Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor? | Biotech Hunter | Biotech Hunter